Your browser doesn't support javascript.
loading
Metformin and survival: Is there benefit in a cohort limited to diabetic women with endometrial, breast, or ovarian cancer?
Lemon, Lara S; Orr, Brian; Modugno, Francesmary; Buckanovich, Ronald J; Coffman, Lan; Edwards, Robert P; Taylor, Sarah.
  • Lemon LS; Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of Pittsburgh, PA 15213, United States of America; Department of Clinical Analytics, University of Pittsburgh Medical Centers, PA 15213, United States of America. Electronic address: lemonl@upmc.edu.
  • Orr B; Division of Gynecologic Oncology, Medical University of South Carolina, Charleston, SC 29425, United States of America.
  • Modugno F; Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of Pittsburgh, PA 15213, United States of America; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, PA 15213, United States of America; Womens Cancer Research Center
  • Buckanovich RJ; Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of Pittsburgh, PA 15213, United States of America.
  • Coffman L; Womens Cancer Research Center, Magee-Womens Research Institute and Hillman Cancer Center, PA 15213, United States of America; Department of Hematology-Oncology, School of Medicine, University of Pittsburgh, PA 15213, United States of America.
  • Edwards RP; Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of Pittsburgh, PA 15213, United States of America.
  • Taylor S; Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of Pittsburgh, PA 15213, United States of America.
Gynecol Oncol ; 165(1): 60-66, 2022 04.
Article en En | MEDLINE | ID: mdl-35140015

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Diabetes Mellitus Tipo 2 / Metformina Tipo de estudio: Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Diabetes Mellitus Tipo 2 / Metformina Tipo de estudio: Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article